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Use of central venous 
catheters in children 
ABSTRACT
The objective of this study was to evaluate the use of central venous catheters (CVCs) in the Pediatric intensive care unit 
(PICU) of Split University Hospital (SUH). We reviewed the records of all children that had CVCs and were hospitalized 
between January 2002 and March 2006. Patients were evaluated with respect to their age, gender, catheter type, indication 
for CVC insertion, site and side of the body of CVC insertion. The duration of catheter use and eventual complications were 
also taken into consideration. A total of 352 CVCs were inserted in 300 children. Patient age ranged from 0 to 18 years. The 
average catheter insertion time was 12.88 days. We noted 66 (18.8%) CVC-related complications. Complications related to 
CVCs insertion were malposition of catheter (5.4%) and pneumothorax (0.9%). Occlusion of CVCs (4.3%), catheter related-
bloodstream infections (CRBI) (4.0%), dislodgment (3.7%) and catheter damage (0.6%) were complications associated 
with lenght of CVCs use. We conclude that central venous catheterization is a safe and efficient procedure with minimal 
complications in pediatric patients.
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INTRODUCTION
Central venous catheters (CVCs) have 
now become indispensable in inten-
sive care units (1-3). Insertion of CVC is 
amongst the most frequently performed 
invasive procedures (2, 3). In severely ill 
and long-stay patients, inserted CVCs 
enable relatively safe and painless appli-
cation of parenteral nutrition, long-term 
antibiotics, chemotherapy, intravenous 
fluids, blood components and is also 
used for repetitive blood sampling (3-6). 
Furthermore, CVCs are used for inva-
sive hemodynamic monitoring, hemo-
dialysis, plasmapheresis and in case of 
shortage of a peripheral access. 
CVCs intended for children are made of 
a variety of materials, including silicone, 
polyurethane, polyvinyl chloride and 
polyethylene (3).
Access to a vessel can be gained via 
percutaneous puncture or with use of 
open surgical techniniques. “Seldinger” 
percutaneous technique is the most fre-
quently used. CVCs are inserted via the 
subclavian vein, internal and external 
jugular veins or umbilical vein in new-
borns. The tip of the catheter can be 
placed into the right atrium, superior or 
high inferior vena cava (7-14). 
When inserting CVC, the operator sho-
uld be very experienced and cautious, 
given that possible complications are 
numerous and some of them can be 
very serious (2, 3, 12). The percentage 
of known catheter-related complications 
range from 0.7 to 26% (1, 3, 12-16). 
The objective of this study was to deter-
mine the frequency of application, indi-
cations and complications of CVCs in 
the Pediatric Intensive Care Unit of the 
Split University Hospital . By analyzing 
the obtained results, our intention was 
to compare them with published data 
pertaining to this issue and to verify our 
methods and procedures.  
MATERIAL AND METHODS
We retrospectively evaluated all patients 
identified as having CVCs from January 
2002 to March 2006 in the PICU of the 
SUH. 
The data on indications for CVC place-
ment, character of illness of patients 
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with CVCs, total number of inserted 
CVCs, the most frequent insertion place 
and side, the average and total number 
of days of CVCs use and the most fre-
quent complications related to CVCs, 
were evaluated. 
All CVCs were placed by a specialized 
team of pediatric intensivists and nurses 
skilled in intensive care procedures and 
were carried out at the bedside. The 
procedures were performed in aseptic 
conditions with continuous monitoring 
of patient’s electrocardiogram, heart 
rate and oxygen saturation. An appro-
priate catheter was chosen on the basis 
of the size of the patient. Polyurethane 
catheters were most commonly used, 
except in case of umbilical insertion 
when a silicone catheter was used. 
One-lumen catheters were used pre-
dominantly. Sedation of the patient was 
achieved with midazolam and fentanyl 
if patient was concuss and vigorous. 
Patients were adequately positioned 
for the procedure. The site of catheter 
insertion was cleaned initially with clor-
hexidin gluconat, with sterile saline and 
finally with clorhexidin in 70% isopro-
pyl alcohol. Standard sterile technique 
- including the use of sterile gloves, 
gown, mask and cap - was used in all 
cases. The place of insertion was cov-
ered with a sterile covering. Catheters 
were inserted percutaneously follow-
ing the Seldinger technique (6, 7). The 
preferred site for primary attempts was 
chosen according to the clinical condi-
tion of the patient. After the catheter 
was inserted, blood flow was checked 
and the lumen was flushed with normal 
saline. Catheters were sutured and cov-
ered with a transparent dressing. The 
catheters were maintained by either 
continuous infusion of heparin (1 unit/
ml) or by heparin flushes of 10 units/ml. 
Within two hours of CVC insertion, chest 
X-rays with contrast were obtained to 
confirm the tip was positioned above 
the pericardium, and to identify poten-
tial complications (8, 15). Two to three 
hours following catheter insertion, a 
patient’s electrocardiogram, heart rate 
and oxygen saturation were monitored. 
Catheter blood flow and insertion site 
were checked and maintained daily. 
Patients were carefully monitored for 
signs of catheter occlusion and cath-
eter-related bloodstream infections 
(CRBI). 
Isolation of the same microorganism 
from the catheter lumen and from the 
blood drawn from a peripheral vein, 
with accompanying clinical symptoms 
of sepsis, was accepted as proof of a 
CRBI (16). Whenever CRBI was diag-
nosed, the catheter was removed, and 
appropriate antibiotics were initiated. 
The frequency of CRBI was ex-pressed 
by number of sepsis cases per 1000 
days of catheter stay.
Catheter malposition was defined as 
placement that required reposition-
ing before use. Catheter damage was 
defined as separation or cracking of cath-
eter line components during use (14).
χ2 test, Kruskal Wallis and Mann-Whit-
ney test were used to determine factors 
associated with complications. A prob-
ability value of  0.05 was accepted as 
significant.
RESULTS
During the study period 1300 patients 
aged from 0 to 18 years were admitted 
to the PICU in SUH. A total of 352 CVCs 
were inserted into 300 patients. There 
were 119 female and 181 male patients 
(39.7% and 60.3% respectively). New-
borns were the biggest age group that 
needed CVC insertion (151, 42.9%) 
(table 1). The difference between the 
number of patients and number of 
inserted CVCs is caused by multiple 
insertions of CVCs in some patients: 
43 (12.2%) had two, 2 (0.6%) had three 
and 1 (0.3%) patient had 4 catheters 
inserted. In two patients, two catheters 
were inserted at the same time because 
of a need for dialysis and parenteral 
nutrition. The average catheter place-
ment time was 12.88 days with a range 
between 1-144 days. The cumulative 
placement time of all inserted CVCs 
was 4532 days. 
The left subclavian vein was the pre-
Table 1. Insertion of CVCs by age group
Age group  Number of patients Number of inserted  
      CVCs (%)
Newborns (0-28 days) 122   151 (42.9)
1 to ≤12 months  59   65 (18.5)
1 to ≤6 years  51   61 (17.3)
6 to ≤12 years  28   30 (8.5)
12 to ≤18 years  40   45 (12.8)
Total   300   352 (100)
Indications    Number of inserted CVCs(%)
Invasive hemodynamic monitoring  65 (18,5)
Dialysis     4 (1,1)
Blood exchange     9 (2,6)
I.v. therapy longer than 14 days   100 (28,4)
Parenteral nutrition    76 (21,6)
Lack of peripheral i.v. access  36 (10,2)
Prematurity    52 (14,8)
Others     10 (2,8)
Total     352 (100)
Table 2. Indications for CVCs insertion 
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ferred place for insertion of CVCs in our 
patients (101 catheters, 28.7%) (picture 
1). The high proposition of newborns 
in our study accounts for the large 
percentage of umbilical vein catheters 
used (89, 25.3%). Two-lumen catheters 
were inserted in 25 patients while one-
lumen catheters were inserted in the 
other patients.
Among the indications for CVC inser-
tion, the need for intravenous therapy 
longer than 14 days was the most fre-
quent reason (table 2). 
Out of total of 352 placed CVCs, 66 
(18.8%) had one of the complications 
related to CVC insertion (table 3). The 
most frequent complication was mal-
position of CVC occuring in 19 (5.4%) 
patients, then occlusion occuring in 15 
(4.3%) patients. Dislodgment occurred 
in 13 (3.7%) patients, but in 8 patients 
it happened after their relocation to the 
Department of Pediatrics. 
The most serious, among all notified 
complications, was CRBI. No catheter 
became infected during the first 48 
hours after insertion. CRBI developed in 
14 (4.0%) patients (table 3). There were 
3.1 CRBI per 1000 catheter-days. In 5, 
out of a total of 14 cases, the isolated 
organism was methicillin-resistant Sta-
phylococcus epidermidis (table 4). 
A significantly higher number of CRBIs 
occurred in newborns than in others 
age groups (χ2=4.20; P=0.040). Three 
times more cases of CRBI were record-
ed when CVCs were inserted for provi-
sion of parenteral nutrition (χ2=11.35; 
P<0.001). CRBI occurred in 6 cases 
when the CVC was inserted into umbili-
cal vein, in 2 cases when it was inserted 
into the left subclavian vein, in 5 cases 
when it was inserted into the right sub-
clavian vein and in 1 case following 
Complications related to CVCs  A total number (%)
Occlusion    15 (4,3)
Malposition    19 (5,4)
CRBI     14 (4,0)
Pneumothorax    3 (0,9)
Dislodgment    13 (3,7)
Catheter damage    2 (0,6)
Total     66 (18,8)
Table 3. Complications related to CVCs insertion and stay 
Organism      Total
Staphylococcus aureus     1
Coagulase-negative Staphylococcus    3
Candida albicans      1
Klebsiella pneumoniae     2
Methicillin-sensitive Staphylococcus epidermidis  1
Methicillin-resistant Staphylococcus epidermidis  5
nonenteric Gram-negative rods    1
Total       14
Table 4. Catheter related-bloodstream infections (CRBI) of inserted CVCs
Table 5. Catheter related-bloodstream infections (CRBI) in relations with other 
CVCs complications 
     Patients with verified complications (N)  P*
     CRBI  Other complications 
Age  Newborns  9  14    0,040
  Others   3  25 
Gender  Female   4  14    0,166
  Male   8  15 
Mechanical 
ventilation Yes   11  29    0,382
  No   1  10 
Indications for 
CVC insertion Parenteral nutrition  9  7    <0,001
  Other indications  3  32 
* χ2 test with Yates correction
23www.signavitae.com
insertion into the right femoral vein. 
CRBI was not significantly associated 
with gender, catheter type or mechani-
cal ventilation (table 5). 
DISCUSSION
Most complications related to CVCs are 
minor, but some of them can be serious 
and can result in patient death (1, 7). 
Our complication rate is within the limits 
of published data. Furthermore, major 
complications in our patients were rare. 
The incidence of the most important 
complication, CRBI, varies from 5% to 
26% in adults (15) and from 3% to 20% 
in children (7).  When calculated in rela-
tion to the length of stay, the incidence 
of CRBIs in adults varies from 2.4 to 12 
per 1000 catheter days (23, 27).The 
incidence is higher in newborns (4.9 epi-
sodes of CRBI per 1000 catheter days), 
than in older children (2.4 episodes of 
CRBI per 1000 days) (19, 20). The low 
incidence of CRBIs in our patients is 
probably related to the expertise of our 
staff members who maintain aseptic 
condition in all procedures involving 
both insertion and managing of CVCs. 
In accordance with published data, 
Coagulase-negative Staphylococcus 
and Methicillin-resistant Staphylococ-
cus epidermidis were the most common 
isolates in our patients with CRBI (7). 
It was found that the duration of the 
catheter use was critical for the occur-
rence of infections (7, 20). When cath-
eters are in place for extended periods, 
the catheter hub probably plays a major 
role in providing access for microor-
ganism to the bloodstream by migrat-
ing endoluminally (20). A higher cath-
eter infection rate was noted in CVCs 
inserted for parenteral nutrition. This 
high rate is associated not only with 
the high concentration of nutrients in 
total parenteral nutrition solutions, but 
also with the length of stay of catheters 
designed for parenteral nutrition (26). 
Likewise, the majority of CRBIs in our 
study occurred in patients who were 
receiving parenteral nutrition, and all our 
patients with CRBIs were newborns. 
The use of multilumen catheters for 
parenteral nutrition is highly desir-
able because it provides multipurpose 
access to central circulation and elimi-
nates a need for additional intravenous 
access (19). However, the multiple 
lumen catheters bear the increased 
risk for CRBI (7, 19 ,21 ,23). This state-
ment is not unequivocal, and the results 
of our study support studies stating that 
multilumen catheters did not increase 
the risk for CRBI (27, 28). It can be 
emphasized again that the adherence 
with the procedures for maintaining 
sterile conditions has a major influence 
on the occurrence of CRBI.
All other complications that occurred 
in our study presented minor problems 
with no influence on morbidity. The most 
common complications during the pro-
cedure of insertion were malposition 
and pneumothorax. The malposition 
of CVCs required repositioning before 
catheter use, but was never associated 
with any further complications. Pneu-
mothorax can be a serious complica-
tion, with the frequency of occurrence 
that varies between 0.01 and 6% (7). 
In our study pneumothorax was only 
an incidental finding, that needed no 
intervention, and with a significantly 
low rate. Other serious complications 
reported in the literature include cardiac 
perforation, arteriovenous fistulas, nerve 
injuries (mostly brachial plexus injuries), 
cardiac tamponade, tension pneumot-
horaces, significant hemothoraces, 
delayed pneumothoraces, life-threaten-
ing arrhythmias, thoracic duct injuries 
and death (1, 24). None of our patients 
had any of these serious complications. 
Thrombosis is reported to occur in 2 to 
67% CVCs (7, 15, 29). We didn’t notice 
any clinically apparent thromboses in 
our patients. However, most thrombo-
ses due to CVCs are asymptomatic (7, 
25, 26). Therefore, ultrasound follow-up, 
that would reveal asymptomatic throm-
bosis, should be performed regularly 
(25, 26, 30). Occlusion of the CVCs was 
one of the most frequent complica-
tions in our study, but again within the 
expected range of 0% - 7% (17, 22). 
When occlusion occurred, it was tried to 
be relieved by flush with urokinase, and 
when urokinase failed we inserted a new 
CVC in the other place.  
Published data on long-term central 
venous access can be compared only 
with great difficulties, due to consider-
able variations in study designs, patient 
populations, access routes and inser-
tion techniques. The rates of infections 
and other complications in our study are 
in accordance with the results obtained 
from the pertinent literature. Therefore, 
we can conclude that percutaneous 
central venous catheterization can be 
recommended as a safe and efficient 
procedure with minimal complications 
in pediatric patients. However, the 
emphasis should be on strict adher-
ence to existing guidelines when CVCs 
are inserted, and during subsequent 
care for CVCs (31). 
Picture 1. Place of CVCs insertion 
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